PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $741,000 | -72.3% | 18,495 | -74.2% | 0.00% | -50.0% |
| Q1 2022 | $2,674,000 | -6.4% | 71,675 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,858,000 | +164.6% | 71,675 | +214.4% | 0.00% | +100.0% |
| Q1 2021 | $1,080,000 | -22.6% | 22,800 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,395,000 | +27.7% | 22,861 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $1,092,000 | -56.3% | 23,353 | -52.6% | 0.00% | -66.7% |
| Q2 2020 | $2,499,000 | -27.2% | 49,242 | -36.0% | 0.00% | -40.0% |
| Q1 2020 | $3,431,000 | -49.4% | 76,902 | -45.5% | 0.01% | -16.7% |
| Q4 2019 | $6,783,000 | +42.2% | 141,230 | +0.5% | 0.01% | +20.0% |
| Q3 2019 | $4,771,000 | +15.1% | 140,462 | +52.5% | 0.01% | +25.0% |
| Q2 2019 | $4,146,000 | +205.1% | 92,122 | +155.1% | 0.00% | +300.0% |
| Q1 2019 | $1,359,000 | -48.9% | 36,114 | -53.9% | 0.00% | -66.7% |
| Q4 2018 | $2,662,000 | +5.7% | 78,348 | +46.2% | 0.00% | +50.0% |
| Q3 2018 | $2,518,000 | +34.3% | 53,585 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $1,875,000 | +173.7% | 55,585 | +119.7% | 0.00% | +100.0% |
| Q1 2018 | $685,000 | – | 25,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |